Elorsa, Dapmie C.

HRN: 24-54-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/09/2024
02/16/2024
IV
600mg
Q6
Cellulitis, Right Foot
Waiting Final Action 
02/18/2024
CEFUROXIME 1.5GM (VIAL)
02/18/2024
02/25/2024
IV DRIP
1.5gm
Q8
UTI
Waiting Final Action 
02/18/2024
CIPROFLOXACIN 500MG (TAB)
02/18/2024
02/25/2024
PO
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: